PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 536.00
-3.00 (-0.56%)
Oct 9, 2025, 1:30 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 198.23 billion as of October 10, 2025. Its market cap has decreased by -12.56% in one year.
Market Cap
198.23B
Enterprise Value
178.39B
Revenue
12.63B
Ranking
n/a
PE Ratio
49.08
Stock Price
536.00
Market Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 198.23B, an increase of 403.33%. That is a compound annual growth rate of 14.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 198.23B | -3.17% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | 24.71B | 2.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |
| Pegavision | 24.14B |